The hidden impact of GLP-1 receptor agonists on endometrial and peritoneal microenvironments
Cell Mol Life Sci 57 : 932942 Werner H, Shalita-Chesner M, Abramovitch S, Idelman G, Shaharabani-Gargir L, Glaser T (2000) Regulation of the insulin-like growth factor-I receptor gene by oncogenes and antioncogenes: implications in human cancer
In the multiple ascending dose study, participants receiving the highest dose level of 48 mg achieved a striking mean body-weight reduction of 9.1% by Day 54, with weight loss trends showing no signs of plateauing
Furthermore, extensive clinical trials with Ozempic have revealed significant cardiovascular benefits, including a reduced risk of major cardiovascular events, such as heart attacks and strokes, in patients with type 2 diabetes who have cardiovascular risk factors
You do need a valid prescription from a licensed clinician